Does DENOSUMAB Cause Hormone-refractory prostate cancer? 26 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 26 reports of Hormone-refractory prostate cancer have been filed in association with DENOSUMAB (Bilprevda). This represents 0.0% of all adverse event reports for DENOSUMAB.
26
Reports of Hormone-refractory prostate cancer with DENOSUMAB
0.0%
of all DENOSUMAB reports
11
Deaths
3
Hospitalizations
How Dangerous Is Hormone-refractory prostate cancer From DENOSUMAB?
Of the 26 reports, 11 (42.3%) resulted in death, 3 (11.5%) required hospitalization, and 1 (3.8%) were considered life-threatening.
Is Hormone-refractory prostate cancer Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DENOSUMAB. However, 26 reports have been filed with the FAERS database.
What Other Side Effects Does DENOSUMAB Cause?
Off label use (34,612)
Death (16,545)
Osteonecrosis of jaw (8,438)
Arthralgia (5,890)
Pain in extremity (4,541)
Back pain (4,465)
Pain (4,102)
Product storage error (3,621)
Fall (3,322)
Fatigue (3,009)
What Other Drugs Cause Hormone-refractory prostate cancer?
RADIUM RA-223 DICHLORIDE (441)
LEUPROLIDE (180)
DOCETAXEL (123)
ENZALUTAMIDE (120)
LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN (110)
DAROLUTAMIDE (104)
ABIRATERONE (83)
PREDNISONE (58)
CABAZITAXEL (57)
BICALUTAMIDE (50)
Which DENOSUMAB Alternatives Have Lower Hormone-refractory prostate cancer Risk?
DENOSUMAB vs DEOXYCHOLIC ACID
DENOSUMAB vs DEPAKINE CHRONO
DENOSUMAB vs DEPAKOTE
DENOSUMAB vs DEPO-PROVERA
DENOSUMAB vs DERMATOPHAGOIDES FARINAE